Change search criteria ↓

Search results

1 387 projects found matching your search criteria:

  1. 451. Bioresorbable, electrospun nonwoven as a multi-drug delivery system for a combination glioblastoma therapy

    Principal investigator: dr Monika Anna Musiał-Kulik

    Centrum Materiałów Polimerowych i Węglowych PAN

    Call: SONATA 17, Panel: NZ7

  2. 452. Novel broad-spectrum central nervous system active substances: optimization of their multi-target profile

    Principal investigator: dr hab. Agnieszka Anna Kaczor

    Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

    Call: OPUS 22, Panel: NZ7

  3. 453. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 17, Panel: NZ7

  4. 454. Inhibition of protein disulfide isomerases as a strategy for reduction of prothrombotic state in atherosclerosis; therap…

    Principal investigator: dr Kamil Przyborowski

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: SONATA 17, Panel: NZ7

  5. 455. New strategies in the treatment of non-small cell lung cancer based on silk nanocarriers targeting tumor vascularization

    Principal investigator: dr Anna Katarzyna Florczak-Substyk

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA 17, Panel: NZ7

  6. 456. Light-producing, oxygen-delivering, cancer cell-targeted carriers for photosensitisers dedicated for photodynamic therap…

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 22, Panel: NZ7

  7. 457. Exosomes as a potential biomarker for monitoring and predicting kidney allograft rejection.

    Principal investigator: dr hab. Justyna Eliza Gołębiewska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  8. 458. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Principal investigator: prof. Paweł Maria Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  9. 459. Studies on anti-inflammatory properties of GPR18 ligands and their involvement in modulation of microglia phenotypes – a…

    Principal investigator: dr hab. Dorota Justyna Łażewska

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22, Panel: NZ7

  10. 460. Species belonging to lichens and bryophytes as a useful source of biologically active compounds in therapy of skin disea…

    Principal investigator: prof. Sławomir Daniel Dresler

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM BIS 3, Panel: NZ7

  11. 461. New immunomodulators of BTLA-HVEM complex as potential therapeutics in systemic lupus erythematosus

    Principal investigator: dr hab. Anna Wardowska

    Gdański Uniwersytet Medyczny, Wydział Lekarski

    Call: OPUS 22, Panel: NZ7

  12. 462. Role of musclin in heart damage repair in patients after myocardial infarction undergoing cardiac rehabilitation.

    Principal investigator: dr Damian Piotr Skrypnik

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA 17, Panel: NZ7

  13. 463. Identification of low molecular weight compounds and peptides with high biological activity present in maggot secretions…

    Principal investigator: dr Katarzyna Joanna Papaj

    Politechnika Śląska, Centrum Biotechnologii

    Call: SONATA 17, Panel: NZ7

  14. 464. Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease

    Principal investigator: prof. Kinga Aleksandra Sałat

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 22 (LAP), Panel: NZ7

  15. 465. Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N…

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 22, Panel: NZ7

  16. 466. Non-provitamin A carotenoids as a novel therapeutic strategy in intestinal failure associated liver disease (IFALD)

    Principal investigator: dr hab. Maciej Jan Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM BIS 3, Panel: NZ7

  17. 467. New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence …

    Principal investigator: prof. Joanna Gabriela Mika

    Instytut Farmakologii PAN

    Call: OPUS 22, Panel: NZ7

  18. 468. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of …

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii PAN

    Call: SONATA 17, Panel: NZ7

  19. 469. The interplay of neurochemistry and cancer biology: in the search for novel glioblastoma multiforme therapy among dopami…

    Principal investigator: dr Katarzyna Maria Kucwaj-Brysz

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA 17, Panel: NZ7

  20. 470. The role of intestinal CYP2E1 in pathophysiology of the gastrointestinal tract disorders: new therapies for leaky gut sy…

    Principal investigator: dr hab. Maciej Stawnisław Sałaga

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM BIS 3, Panel: NZ7

  21. 471. Antithrombotic, haemodynamic and redox effects of novel HNO donors

    Principal investigator: dr hab. Karol Franciszek Kramkowski

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 22, Panel: NZ7

  22. 472. Extracellular vesicles produced by Bifidobacterium as novel approach fortreatment of allergy diseases

    Principal investigator: dr hab. Sabina Barbara Górska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: OPUS 22 (LAP), Panel: NZ7

  23. 473. Asymmetrical flow field-flow fractionation for gentle isolation of lipid-based nanoparticles biomolecule corona complexe…

    Principal investigator: dr hab. Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: SONATA BIS 11, Panel: NZ7

  24. 474. Photoswitchable and chimeric molecules for spatially restricted and endoplasmic reticulum-specific blockade of PD-L1 pro…

    Principal investigator: dr Łukasz Dariusz Skalniak

    Uniwersytet Jagielloński, Wydział Chemii

    Call: SONATA BIS 11, Panel: NZ7

  25. 475. Neurobiological mechanisms of migraine pain - role of opioid and NOP systems

    Principal investigator: dr hab. Katarzyna Małgorzata Targowska-Duda

    Uniwersytet Medyczny w Lublinie

    Call: SONATA BIS 11, Panel: NZ7

  26. 476. Ionophore coccidiostats: risk of CO-selection of antimicrobial resistance - Clinical impact and intervention strategies

    Principal investigator: dr Jowita Samanta Niczyporuk

    Państwowy Instytut Weterynaryjny - Państwowy Instytut Badawczy

    Call: JPIAMR-ACTION Call 2021, Panel: NZ7

  27. 477. New graphene-based approach targeting the prion-like propagation of α-synuclein in Parkinson's disease.

    Principal investigator: dr hab. Małgorzata Kujawska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA BIS 11, Panel: NZ7

  28. 478. Specific Targeting of Antimicrobial Resistant Strains in situ using Targeted-Antibacterial-Plasmids

    Principal investigator: dr Anna Marzec-Grządziel

    Instytut Uprawy Nawożenia i Gleboznawstwa - Państwowy Instytut Badawczy

    Call: JPIAMR-ACTION Call 2021, Panel: NZ7

  29. 479. 3D printing as a tool to obtain transdermal microneedle systems with improved efficiency in the treatment of depressive …

    Principal investigator: prof. Tomasz Zbigniew Osmałek

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: SONATA BIS 11, Panel: NZ7

  30. 480. RE-SENSE: Dual-loaded lipid nanoparticles to overcome the resistance of non-small cell lung cancer cells to personalized…

    Principal investigator: Mikołaj Czajkowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  31. 481. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr…

    Principal investigator: Marta Kędziora

    Instytut Farmakologii PAN

    Call: PRELUDIUM 20, Panel: NZ7

  32. 482. Analysis of the expression of NANOS and PUMILIO proteins and epithelial-mesenchymal transition markers in gastroenteropa…

    Principal investigator: Patryk Kraiński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: PRELUDIUM 20, Panel: NZ7

  33. 483. Examining the response to exercise using a systems biology approach in race horses

    Principal investigator: dr Olga Danuta Witkowska-Piłaszewicz

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Medycyny Weterynaryjnej

    Call: OPUS 21, Panel: NZ7

  34. 484. Combating addiction by targeting α3β4*-nicotinic acetylcholine receptors

    Principal investigator: dr Ákos Nemecz

    Uniwersytet Mikołaja Kopernika, Wydział Nauk Biologicznych i Weterynaryjnych

    Call: OPUS 21, Panel: NZ7

  35. 485. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

    Principal investigator: prof. Barbara Malinowska

    Uniwersytet Medyczny w Białymstoku

    Call: OPUS 21, Panel: NZ7

  36. 486. Bioabsorbable hydroxyapatite/polymer nanocomposite granules with enhanced osteoconductivity and anti-inflammatory proper…

    Principal investigator: dr Vladyslav Vivcharenko

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 20, Panel: NZ7

  37. 487. Anticancer activity of novel derivatives of 9,10-Anthraquinone Dithiocarbamates

    Principal investigator: Natalia Anna Maciejewska

    Politechnika Gdańska

    Call: PRELUDIUM 20, Panel: NZ7

  38. 488. PDMS-based specially designed microfluidic channel lined with primary endothelial cells: a novel tool for experimental p…

    Principal investigator: Stefano Rocchetti

    Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

    Call: PRELUDIUM 20, Panel: NZ7

  39. 489. Impact of voluntary physical activity and exercise mimetics on the neuroinflammation-related changes induced by an estro…

    Principal investigator: dr Konstancja Imogena Grabowska

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: PRELUDIUM 20, Panel: NZ7

  40. 490. Comprehensive research of the Bifidobacterium lipoteichoic acids - structural and functional studies extended by the sca…

    Principal investigator: Katarzyna Pacyga-Prus

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 20, Panel: NZ7

  41. 491. Pharmacological potential of mistletoe (Viscum album L.) in the prevention of central nervous system disorders.

    Principal investigator: Anna Szurpnicka

    Narodowy Instytut Leków

    Call: PRELUDIUM 20, Panel: NZ7

  42. 492. New type of analogs and conjugates of folic acid with potential therapeutic applicaton in treatment of hormone-dependent…

    Principal investigator: Olga Ciupak

    Politechnika Gdańska, Wydział Chemiczny

    Call: PRELUDIUM 20, Panel: NZ7

  43. 493. Cognitive frailty in patients with heart failure: the role of cardiovascular factors and frailty syndrome.

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

    Call: OPUS 21, Panel: NZ7

  44. 494. Switchable with visible light cisplatin analogs and complexes of selected transition metals - photochemical and anticanc…

    Principal investigator: prof. Krzysztof Szczubiałka

    Uniwersytet Jagielloński, Wydział Chemii

    Call: OPUS 21, Panel: NZ7

  45. 495. Genetic and epigenetic interaction of exposure to endocrine disrupting chemicals included in everyday use products and e…

    Principal investigator: prof. Joanna Katarzyna Jurewicz

    INSTYTUT MEDYCYNY PRACY IM.PROF.DR MED.JERZEGO NOFERA W ŁODZI

    Call: OPUS 21, Panel: NZ7

  46. 496. New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil…

    Principal investigator: Marcin Konrad Jakubiec

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 20, Panel: NZ7

  47. 497. Estrogenic mycotoxins (ZEA, α-ZOL) and tumor progression - an in vitro model of obesity and breast cancer

    Principal investigator: dr Kinga Anna Urbanek

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: PRELUDIUM 20, Panel: NZ7

  48. 498. Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to …

    Principal investigator: prof. Janusz Edward Kasperczyk

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

    Call: OPUS 21, Panel: NZ7

  49. 499. Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of …

    Principal investigator: prof. Piotr Wiktor Wlaź

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii

    Call: OPUS 21, Panel: NZ7

  50. 500. Interplay between neuroplasticity and CC/CXC chemokine inflamatory pathways in depression.

    Principal investigator: prof. Tomasz Adam Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: OPUS 21, Panel: NZ7

Only the first 500 are shown — narrow your search.

Graphic design and implementation: Jakub Piotrowski